Empowering
life science ventures
to scale effectively
About
Drawing from 50+ peer interviews and 101 real-world lessons, Scaling Life Sciences presents the Life Science Scaling Matrix™ and three practical tools for scaling success.
Author
Martin Stenfeldt, award-winning entrepreneur and life science thought-leader, distills 30 years of corporate and scaleup experience, sharing insights from his journey and global peer network.
Insights
Explore beyond the book with research insights, practical tool templates, best practice white papers, expert interviews, case studies, LinkedIn posts, author commentary, and recommended readings.
Services
Scaling Life Sciences is a growth advisory firm and publishing house, supporting life science ventures with expertise from the book Scaling Life Sciences. We help companies navigate their scaling journey by focusing on the critical intersection of product, market, and people to drive sustainable venture scaling.
Our Services:
- Team Workshops: Aligning teams, refining strategies, and driving execution.
- Training Programs: Building leadership capabilities for scaling challenges.
- Board & Leadership Evaluations: Providing objective assessments to strengthen governance and fascilitating robust board/leadership collaboriation.
- 1:1 Leadership Advisory: Offering personalized venture coaching for life science leaders
The Eight Archetypes of Life Science Entrepreneurs
The personalities driving a company’s scaling journey deeply influence its success. Overlooking these traits at key growth stages can be costly. This framework, inspired by Carl Gustav Jung’s concept of archetypes, stems from the book’s research and industry observations. It provides a shared language for understanding how leadership styles shape opportunities and risks during scaling.
The eight archetypes—The Engineer, The Marketeer, The Clinician, The Scientist, The Caring Activist, The Anarchist, The Corporate Suit, and The Serial Entrepreneur—highlight distinct personality traits that impact decision-making, strategy, and outcomes in life science ventures. Recognizing these archetypes offers insight into how key players drive success or expose vulnerabilities.